A population-based study of measles, mumps, and rubella vaccination and autism

New England Journal of Medicine

Volumn 347, Issue 19, 2002, Pages 1477-1482

  Madsen, Kreesten Meldgaard ^a   Hviid, Anders ^b   Vestergaard, Mogens ^a   Schendel, Diana ^c   Wohlfahrt, Jan ^b   Thorsen, Poul ^a   Olsen, Jørn ^a   Melbye, Mads ^b  

^a UNIVERSITY OF AARHUS   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; AUTISM; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASLES VACCINATION; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; STATISTICS; VACCINATION;

AUTISTIC DISORDER; BIRTH WEIGHT; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DENMARK; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; REGISTRIES; RETROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 0037038217     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021134     Document Type: Article

References (36)

1. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
2. Stratton K, Gable A, Shetty P, McCormick M, eds. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, D.C.: National Academy Press, 2001.
3. Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: Through a glass, darkly. Adverse Drug React Toxicol Rev 2000;19:265-83.
4. Autism: Present Challenges, Future Needs - Why the Increased Rates? Hearing Before the Committee of Government Reform, U.S. House of Representatives, 106th Congress, Second Session, April 6, 2000. Washington, D.C.: Government Printing Office, 2000.
5. Department of Developmental Services. Changes in the Population of Persons with Autism and Pervasive Developmental Disorders in California's Developmental Services System: 1987 Through 1998: A Report to the Legislature. Sacramento: California Health and Human Services Agency, March 1999.
6. Uhlmann V, Martin CM, Sheils O, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 2002;55:84-90.
7. Griffin DE, Ward BJ, Jauregui E, Johnson RT, Vaisberg A. Immune activation in measles. N Engl J Med 1989;320:1667-72.
8. Singh VK, Lin SX, Newell E, Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci 2002;9:359-64.
9. Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis - Clinical and immunologic studies. N Engl J Med 1984;310:137-41.
10. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association. Lancet 1999;353:2026-9.
11. Kaye JA, del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. BMJ 2001;322:460-3.
12. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA 2001;285:1183-5.
13. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001;108:991. abstract.
14. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 2000;19:1127-34.
15. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Pannio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998;351:1327-8.
16. Taylor B, Miller E, Lingram L, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study. BMJ 2002;324:393-6.
17. Causality assessment of adverse events following immunization. Wkly Epidemiol Rec 2001;76:85-9.
18. Smeeth L, Hall AJ, Rodrigues LC, Huang X, Smith PG, Fombonne E. Measles, mumps, and rubella (MMR) vaccine and autism: Ecological studies cannot answer main question. BMJ 2001;323:163.
19. Edwardes M, Baltzan M. MMR immunization and autism. JAMA 2001;285:2852-3.
20. Measles, MMR, and autism: The confusion continues. Lancet 2000;355:1379.
21. Malig C. The Civil Registration System in Denmark. IIVRS Technical Paper No. 66. Bethesda, Md.: International Institute for Vital Registration and Statistics, 1996.
22. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997;44:82-4.
23. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.
24. Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999;29:439-84. [Erratum, J Autism Dev Disord 2000;30:81.]
25. Volkmar FR, Klin A, Siegel B, et al. Field trial for autistic disorder in DSM-IV. Am J Psychiatry 1994;151:1361-7
26. Hill A, Bolte S, Petrova G, Beltcheva D, Tacheva S, Poustka F. Stability and interpersonal agreement of the interview-based diagnosis of autism. Psychopathology 2001;34:187-91.
27. Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. Prevalence of autism in a United States population: The Brick Township, New Jersey, investigation. Pediatrics 2001;108:1155-61.
28. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998;45:320-31.
29. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register: A valuable source of data for modern health sciences. Dan Med Bull 1999;46(3):263-8.
30. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford, England: Oxford University Press, 1993.
31. Vellinga A, Depoorter AM, Van Damme P. Vaccination coverage estimates by EPI cluster sampling survey of children (18-24 months) in Flanders, Belgium. Acta Paediatr 2002;91:599-603.
32. Epidemiology and Prevention of Vaccine-Preventable Diseases. 7th Ed. Atlanta: Centers for Disease Control and Prevention, 2002.
33. Burd L, Fisher W, Kerbeshian J. A prevalence study of pervasive developmental disorders in North Dakota. J Am Acad Child Adolesc Psychiatry 1987;26:700-3.
34. Baird G, Charman T, Baron-Cohen S, et al. A screening instrument for autism at 18 months of age: A 6-year follow-up study. J Am Acad Child Adolesc Psychiatry 2000;39:694-702.
35. Fombonne E, Du Mazaubrun C, Cans C, Grandjean H. Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry 1997;36:1561-9.
36. Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002;32:207-15.